Griffin Asset Management’s Novartis NVS Stock Holding History

Griffin Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,769	Closed	-$308K	–	242
2021 Q3	$308K	Sell	3,769 -2,850	-43%	-$256K	0.04%	204
2021 Q2	$604K	Sell	6,619 -2,897	-30%	-$258K	0.07%	167
2021 Q1	$813K	Sell	9,516 -6,032	-39%	-$541K	0.1%	143
2020 Q4	$1.47M	Sell	15,548 -32,110	-67%	-$2.81M	0.19%	108
2020 Q3	$4.14M	Sell	47,658 -2,238	-4%	-$194K	0.64%	44
2020 Q2	$4.36M	Sell	49,896 -299	-0.6%	-$25.8K	0.7%	45
2020 Q1	$4.14M	Buy	50,195 +720	+1%	+$64.2K	0.78%	39
2019 Q4	$4.68M	Sell	49,475 -75	-0.2%	-$6.73K	0.66%	46
2019 Q3	$4.31M	Sell	49,550 -5,337	-10%	-$479K	0.67%	46
2019 Q2	$5.01M	Sell	54,887 -6,324	-10%	-$535K	0.64%	46
2019 Q1	$5.27M	Sell	61,211 -848	-1%	-$68.1K	0.75%	41
2018 Q4	$4.77M	Sell	62,059 -1,246	-2%	-$97K	0.81%	41
2018 Q3	$4.89M	Buy	63,305 +865	+1%	+$63.9K	0.72%	44
2018 Q2	$4.23M	Sell	62,440 -2,055	-3%	-$142K	0.77%	43
2018 Q1	$4.67M	Buy	64,495 +919	+1%	+$70K	0.85%	41
2017 Q4	$4.78M	Sell	63,576 -4,571	-7%	-$345K	0.85%	44
2017 Q3	$5.24M	Buy	68,147 +831	+1%	+$62.8K	0.95%	37
2017 Q2	$5.04M	Buy	+67,316	New	+$4.77M	1.35%	28
2015 Q4	$4.03M	Buy	52,328 +452	+0.9%	+$35.9K	1.7%	27
2015 Q3	$4.27M	Sell	51,876 -8,539	-14%	-$760K	1.78%	23
2015 Q2	$5.32M	Sell	60,415 -159	-0.3%	-$14.6K	2.04%	22
2015 Q1	$5.35M	Sell	60,574 -7,076	-10%	-$628K	1.55%	27
2014 Q4	$5.62M	Sell	67,650 -3,242	-5%	-$269K	1.49%	24
2014 Q3	$5.98M	Sell	70,892 -422	-0.6%	-$34.1K	1.78%	22
2014 Q2	$5.79M	Sell	71,314 -828	-1%	-$65.1K	1.81%	21
2014 Q1	$5.5M	Sell	72,142 -4,715	-6%	-$344K	1.78%	21
2013 Q4	$5.54M	Buy	76,857 +1,200	+2%	+$83.4K	1.79%	21
2013 Q3	$5.2M	Sell	75,657 -960	-1%	-$63.5K	1.7%	22
2013 Q2	$4.85M	Buy	+76,617	New	+$4.98M	1.76%	21

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Griffin Asset Management's NVS Position: Q4 2021 in Review

Griffin Asset Management sold out of Novartis (NVS) in Q4 2021, closing a stake of 3,769 shares — an estimated $308K sold.

Griffin Asset Management first reported a position in NVS in Q2 2013 and held it in 29 quarters. The position peaked at $5.98M in Q3 2014. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

Griffin Asset Management reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
Griffin Asset Management sold 3,769 Novartis shares in Q4 2021, an estimated $308K.
Griffin Asset Management first reported a position in Novartis in Q2 2013 and held it in 29 quarters.
Griffin Asset Management's Novartis position peaked at $5.98M in Q3 2014.
1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Griffin Asset Management's 13F filing for Q4 2021, filed 28 Jan 2022.